The TP53 fertility network

Genetics and Molecular Biology

Volumn 35, Issue 4 SUPPL., 2012, Pages 939-946

  Paskulin, Diego D'Avila ^a,b   Paixão Côrtes, Vanessa Rodrigues ^a   Hainaut, Pierre ^c   Bortolini, Maria Cátira ^a   Ashton Prolla, Patricia ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Fertility; P53 network; TP53

Indexed keywords

PROTEIN P53;

AUTOPHAGY; FEMALE FERTILITY; FEMALE INFERTILITY; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE PRODUCT; GENETIC VARIABILITY; GENOTYPE; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 84872463245     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572012000600008     Document Type: Review

References (49)

1. Atwal GS, Bond GL, Metsuyanim S, Papa M, Friedman E, Distelman-Menachem T, Ben Asher E, Lancet D, Ross DA, Sninsky J, et al. (2007). Haplotype structure and selection of the MDM2 oncogene in humans. Proc Natl Acad Sci USA 104:4524-4529.
2. Atwal GS, Kirchhoff T, Bond EE, Montagna M, Menin C, Bertorelle R, Scaini MC, Bartel F, Bohnke A, Pempe C, et al. (2009) Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene. Proc Natl Acad Sci USA 106:10236-10241.
3. Belyi VA, Ak P, Markert E, Wang H, Hu W, Puzio-Kuter A and Levine AJ (2010) The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 2:a001198.
4. Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, Dinarello CA and Paul WE (2009) IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci USA 106:7119-7124.
5. Bianco B, Christofolini DM, Brandes A, Lerner TG, Gonçalves-Filho RP, Souza AM and Barbosa CP (2011) Analysis of codon 72 polymorphism of the TP53 gene in infertile women with and without endometriosis. Rev Bras Ginecol Obstet 33:37-42 (in portuguese).
6. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, et al. (2004) A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119:591-602.
7. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK and Lane DP (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19:2122-2137.
8. Chen JR, Cheng JG, Shatzer T, Sewell L, Hernandez L and Stewart CL (2000) Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 141:4365-4372.
9. Chen L, Zhao P, Wells L, Amemiya CT, Condie BG and Manley NR (2010) Mouse and zebrafish Hoxa3 orthologues have nonequivalent in vivo protein function. Proc Natl Acad Sci USA 107:10555-10560.
10. de Magalhaes JP and Church GM (2005) Genomes optimize reproduction: Aging as a consequence of the developmental program. Physiology (Bethesda) 20:252-259.
11. Dumon P, Leu JI, Della Pietra 3rd AC, George DL and MurphyM (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357-365.
12. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S and Levine A J (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67:3043-3053.
13. Feng Z, Zhang C, Kang HJ, Sun Y, Wang H, Naqvi A, Frank AK, Rosenwaks Z, Murphy ME, Levine AJ, et al. (2011) Regulation of female reproduction by p53 and its family members. FASEB J 25:2245-2255.
14. Gardner RD and Burke DJ (2000) The spindle checkpoint: Two transitions, two pathways. Trends Cell Biol 10:154-158.
15. Gonfloni S, Di Tella L, Caldarola S, Cannata SM, Klinger FG, Di Bartolomeo C, Mattei M, Candi E, De Felici M, Melino G, et al. (2009) Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med 15:1179-1185.
16. Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, Kircher M, Patterson N, Li H, Zhai W, Fritz MH, et al. (2010) A draft sequence of the Neandertal genome. Science 328:710-722.
17. Hoh J, Jin S, Parrado T, Edington J, Levine AJ and Ott J (2002) The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA 99:8467-8472.
18. HollsteinMand Hainaut P (2010) Massively regulated genes: The example of TP53. J Pathol 220:164-173.
19. Hooper AT, Shmelkov SV, Gupta S, Milde T, Bambino K, Gillen K, Goetz M, Chavala S, Baljevic M, Murphy AJ, et al. (2009) Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-Adependent neoangiogenesis. Circ Res 105:201-208.
20. Hu W, Feng Z, Ma L, Wagner J, Rice JJ, StolovitzkyGand Levine AJ (2007a) Asingle nucleotide polymorphism in theMDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells. Cancer Res 67:2757-2765.
21. Hu W, Feng Z, Teresky AK and Levine AJ (2007b) p53 regulates maternal reproduction through LIF. Nature 450:721-724.
22. Kang HJ, Feng Z, Sun Y, Atwal G, Murphy ME, Rebbeck TR, Rosenwaks Z, Levine AJ and Hu W (2009) Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proc Natl Acad Sci USA 106:9761-9766.
23. Kay C, Jeyendran RS and Coulam CB (2006) p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reprod Biomed Online 13:492-496.
24. Kruse JP and Gu W (2009) Modes of p53 regulation. Cell 137:609-622.
25. Lain S and Lane D (2003) Improving cancer therapy by non-genotoxic activation of p53. Eur J Cancer 39:1053-1060.
26. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15-16.
27. Levine AJ, Tomasini R, McKeon FD, Mak TW and Melino G (2011) The p53 family: Guardians of maternal reproduction. Nat Rev Mol Cell Biol 12:259-265.
28. Lindsay J, McDade SS, Pickard A, McCloskey KD and McCance DJ (2011) Role of DeltaNp63gamma in epithelial to mesenchymal transition. J Biol Chem 286:3915-3924.
29. Lu WJ, Amatruda JF and Abrams JM (2009) p53 ancestry: Gazing through an evolutionary lens. Nat Rev Cancer 9:758-762.
30. Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.
31. Michael D and Oren M (2003) The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13:49-58.
32. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.
33. Nedelcu AM and Tan C (2007) Early diversification and complex evolutionary history of the p53 tumor suppressor gene family. Dev Genes Evol 217:801-806.
34. Oh JE, Kim RH, Shin KH, Park NH and Kang MK (2011) DeltaNp63alpha protein triggers epithelial-mesenchymal transition and confers stem cell properties in normal human keratinocytes. J Biol Chem 286:38757-38767.
35. Phelps M, Darley M, Primrose JN and Blaydes JP (2003) p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells. Cancer Res 63, 2616-2623.
36. Plunkett J, Doniger S, Orabona G, Morgan T, Haataja R, Hallman M, Puttonen H, Menon R, Kuczynski E, Norwitz E, et al. (2011) An evolutionary genomic approach to identify genes involved in human birth timing. PLoS Genetics 7:e1001365.
37. Reich D, Green RE, Kircher M, Krause J, Patterson N, Durand EY, Viola B, Briggs AW, Stenzel U, Johnson PL, et al. (2010) Genetic history of an archaic hominin group from Denisova Cave in Siberia. Nature 468:1053-1060.
38. Ribeiro Junior CL, Arruda JT, Silva CT and Moura KK (2009) Analysis of p53 codon 72 gene polymorphism in Brazilian patients with endometriosis. Genet Mol Res 8:494-499.
39. Shan J, Brooks C, Kon N, LiMand GuW (2008) Dissecting roles of ubiquitination in the p53 pathway. Ernst Schering Found Symp Proc 2008-1:127-136.
40. Shi H, Tan SJ, Zhong H, Hu W, Levine A, Xiao CJ, Peng Y, Qi XB, Shou WH, Ma RL, et al. (2009) Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in eastern Asia. Am J Hum Genet 84:534-541.
41. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F and Abbondanzo SJ (1992) Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359:76-79.
42. Straub WE, Weber TA, Schafer B, Candi E, Durst F, Ou HD, Rajalingam K, Melino G and Dotsch V (2010) The C-terminus of p63 contains multiple regulatory elements with different functions. Cell Death Dis 1:e5.
43. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al. (2011) The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39:D561-D568.
44. Tagliani-Ribeiro A, Oliveira M, Sassi AK, Rodrigues MR, Zagonel-Oliveira M, Steinman G, Matte U, Fagundes NJ and Schuler-Faccini L (2011) Twin Town in South Brazil: A Nazi's experiment or a genetic founder effect? PLoS One 6:e20328.
45. Tagliani-Ribeiro A, Paskulin DD, Oliveira M, Zagonel-Oliveira M, Longo D, Ramallo V, Ashton-Prolla P, Saraiva-Pereira ML, Fagundes NJ, Schuler-Faccini L, et al. (2012) High twinning rate in Cândido Godói: A new role for p53 in human fertility. Hum Reprod 27:2866-71.
46. Thomas M, Kalita A, Labrecque S, Pim D, Banks L and Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092-1100.
47. Toledo F, Krummel KA, Lee CJ, Liu CW, Rodewald LW, TangM and Wahl GM (2006) A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell 9:273-285.
48. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, Wakeham A, Tsao MS, et al. (2008) TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 22:2677-2691.
49. Vousden KH and Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413-431.